Quick Takeaways
- MORGAN STANLEY filed SCHEDULE 13G/A for TENAX THERAPEUTICS, INC. Common Stock (TENX).
- Disclosed ownership: 3.5%.
- Date of event: 31 Mar 2026.
MORGAN STANLEY - 31 Mar 2026 SCHEDULE 13G/A Report for TENAX THERAPEUTICS, INC. Common Stock (TENX)
- Filing Manager
- MORGAN STANLEY
- Reporting Manager
- Morgan Stanley
- Symbol
- TENX
- Shares outstanding
- 17,044,686 shares
- Disclosed Ownership
- 596,564 shares
- Ownership
- 3.5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 08 Apr 2026, 18:26:03 UTC
- Date of event
- 31 Mar 2026
- Previous filing
- 12 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"MORGAN STANLEY disclosed 3.5% ownership in TENAX THERAPEUTICS, INC. Common Stock (TENX) on 31 Mar 2026."
What Changed
- Previous schedule filing date: 12 Feb 2026.
- Current filing was accepted on 08 Apr 2026, 18:26.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | 3.5% | 596,564 | 0 | 592,504 | Claire Gordon | Authorized Signatory, Morgan Stanley | |
| Morgan Stanley Capital Services LLC | 3.4% | 583,297 | 0 | 583,297 | Claire Gordon | Authorized Signatory, Morgan Stanley Capital Services LLC |